Sanofi made False Claims about RSV Shot for Infants FDA says

"In a letter to the drugmaker, the FDA said the agency approved Beyfortus, an RSV monoclonal antibody, as a defense against RSV lower respiratory tract disease — but that Sanofi has been claiming it protects broadly against RSV disease, which occurs in the lower and upper tracts. Beyfortus has come under scrutiny following reports of at least two infant deaths during clinical trials for the drug."

https://tdefender.substack.com/.../sanofi-false-claims...

https://www.fiercepharma.com/marketing/fda-untitled-letter-calls-out-sanofi